Properly Diagnosing & Treating C. Difficile

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Feuerstadt, MD, FACG, AGAF

In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.